Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature

Detalles Bibliográficos
Autores principales: Linch, Stefanie, Kasiewicz, Melissa J, McNamara, Michael, Hilgart, Ian, Farhad, Mohammad, Redmond, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649323/
http://dx.doi.org/10.1186/2051-1426-3-S2-P306
_version_ 1782401333124399104
author Linch, Stefanie
Kasiewicz, Melissa J
McNamara, Michael
Hilgart, Ian
Farhad, Mohammad
Redmond, William
author_facet Linch, Stefanie
Kasiewicz, Melissa J
McNamara, Michael
Hilgart, Ian
Farhad, Mohammad
Redmond, William
author_sort Linch, Stefanie
collection PubMed
description
format Online
Article
Text
id pubmed-4649323
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46493232015-11-24 Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature Linch, Stefanie Kasiewicz, Melissa J McNamara, Michael Hilgart, Ian Farhad, Mohammad Redmond, William J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649323/ http://dx.doi.org/10.1186/2051-1426-3-S2-P306 Text en Copyright © 2015 Linch et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Linch, Stefanie
Kasiewicz, Melissa J
McNamara, Michael
Hilgart, Ian
Farhad, Mohammad
Redmond, William
Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
title Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
title_full Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
title_fullStr Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
title_full_unstemmed Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
title_short Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature
title_sort galectin-3 inhibition using novel inhibitor gr-md-02 improves survival and immune function while reducing tumor vasculature
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649323/
http://dx.doi.org/10.1186/2051-1426-3-S2-P306
work_keys_str_mv AT linchstefanie galectin3inhibitionusingnovelinhibitorgrmd02improvessurvivalandimmunefunctionwhilereducingtumorvasculature
AT kasiewiczmelissaj galectin3inhibitionusingnovelinhibitorgrmd02improvessurvivalandimmunefunctionwhilereducingtumorvasculature
AT mcnamaramichael galectin3inhibitionusingnovelinhibitorgrmd02improvessurvivalandimmunefunctionwhilereducingtumorvasculature
AT hilgartian galectin3inhibitionusingnovelinhibitorgrmd02improvessurvivalandimmunefunctionwhilereducingtumorvasculature
AT farhadmohammad galectin3inhibitionusingnovelinhibitorgrmd02improvessurvivalandimmunefunctionwhilereducingtumorvasculature
AT redmondwilliam galectin3inhibitionusingnovelinhibitorgrmd02improvessurvivalandimmunefunctionwhilereducingtumorvasculature

Ejemplares similares